Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rank in Stocks #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Share Price
$2.20
Last synced: 2026-09-01
Market Cap
$253.81M
Change (1 day)
10.29%
Change (1 year)
99.67%
Country
CA
Trade Cardiol Therapeutics Inc. (CRDL)

Category

Stock price history for Cardiol Therapeutics Inc. (CRDL)
Highest end of day price: $2.20 on 2026-09-01

Lowest end of day price: $3.27 on 2018-12-01
Stock price history of Cardiol Therapeutics Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 16.76%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$164.22 30.66%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.53 25.84%
CH